Company
LON:FIPP
Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs. The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.
362 stories · page 5 of 19
The company said the fair value of its equity portfolio increased by 24% to £39,712,000 after disposals of £3,659,000 (2021: nil) and additions of £1,378,000 (2021: £347,000)
Elute’s linguistic software enables computers to make rapid detailed comparisons of texts, detecting for plagiarism and collusion, and allowing automatic summaries of documents
Talks are underway with potential manufacturers while distribution agreements have been signed
The original cost for these shares was less than £2,000
CamGraPhIC specialises in graphene technology that helps telecoms and data networks operate more effectively
CRI was valued at £6.1mln post the new money compared to £1.5mln at the time of its previous fundraise
The company celebrated the first successful listing of one of its portfolio companies, with Exscientia floating on Nasdaq with a US$2.9bn valuation
Exscientia uses artificial intelligence to modernise the way new medicines are discovered and developed
The CHARM project will receive €3.3mln in total, with CRI’s share €1.3mln
It found buyers for 183,901 American depositary shares in Exscientia at an average price of US$21.68, netting US$4mln for a ‘realised gain’ of US$1.9mln
The investment company has now started to sell down its stake in the AI-based drug developer
Frontier invests in early-stage businesses and helps commercialise intellectual property
A glance at some of the day's highlights from the Proactive Investors newswire
Data from The Vaccines Group revealed its herpesvirus-based jab stimulated a strong T cell response when used on pigs
Archive
Frontier IP Group (“Frontier IP”) provides commercialisation services in return for equity in private technology companies across four high growth technology clusters comprising: artificial intelligence, robotics and big and sparse data; pa
The fair value of the portfolio rose by 64% to £32mln, while profit before tax increased by 145% to £10.2mln
Archive
Portfolio Company Exscientia intention to IPO in the U.S. and CamGraPhIC fund raise Frontier IP Group (LON:FIPP) works with technology companies, typically university spinouts, to commercialise intellectual property in return for equity sta
The American Depositary Shares are expected to begin trading on the Nasdaq Global Select Market later today under the ticker symbol "EXAI."
It values the University of Cambridge spinout at £5.6mln
Frontier IP stressed that at this stage there can be no certainty on the IPO proceeding nor the terms or timing of the IPO
